Apogee Therapeutics, Inc. (APGE) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 9 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for APGE is $105.63, representing a +19.4% upside from the current price of $88.47. Price targets range from a low of $83.00 to a high of $137.00.
